Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · Real-Time Price · USD
8.62
+0.02 (0.29%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Theravance Biopharma Employees
Theravance Biopharma had 97 employees as of December 31, 2024. The number of employees decreased by 2 or -2.02% compared to the previous year.
Employees
97
Change (1Y)
-2
Growth (1Y)
-2.02%
Revenue / Employee
$663,722
Profits / Employee
-$581,629
Market Cap
426.44M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
TBPH News
- 11 days ago - Theravance Biopharma Presents Two New Ampreloxetine Analyses in Oral Session at the American Academy of Neurology 2025 Annual Meeting - PRNewsWire
- 18 days ago - Theravance Biopharma to Participate in an Upcoming Investor Conference - PRNewsWire
- 22 days ago - Theravance Biopharma to Present New Ampreloxetine Analyses in Neurogenic Orthostatic Hypotension (nOH) at the 77th Annual Meeting of the American Academy of Neurology - PRNewsWire
- 7 weeks ago - Theravance Biopharma, Inc. (TBPH) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Theravance Biopharma, Inc. Reports Record Fourth Quarter and Full Year 2024 Financial Results - PRNewsWire
- 2 months ago - Theravance Biopharma to Report Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025 - PRNewsWire
- 4 months ago - Theravance Biopharma to Conduct Investor Meetings During the J.P. Morgan 43rd Annual Healthcare Conference - PRNewsWire
- 5 months ago - Theravance Biopharma, Inc. (TBPH) Q3 2024 Earnings Call Transcript - Seeking Alpha